PT Kalbe Farma Tbk (FRA:LCLA) Future 3-5Y EPS without NRI Growth Rate : 11.44 (As of Sep. 23, 2024)

View and export this data going back to 2004. Start your Free Trial

What is PT Kalbe Farma Tbk Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, PT Kalbe Farma Tbk's Future 3-5Y EPS without NRI Growth Rate is 11.44.

Competitive Comparison of PT Kalbe Farma Tbk's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Kalbe Farma Tbk's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's Future 3-5Y EPS without NRI Growth Rate falls into.

PT Kalbe Farma Tbk (FRA:LCLA) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

PT Kalbe Farma Tbk Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Kalbe Farma Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (FRA:LCLA) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

PTKFY:USA PTKFF:USA KLBF:Indonesia

Address

Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510

Website

https://www.kalbe.co.id

Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk Headlines

No Headlines